参考文献
2020-10-19
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
Philip A. Harris, Jill M. Marinis, John D. Lich, Scott B. Berger, Anirudh Chirala, Julie A. Cox, Patrick M. Eidam, Joshua N. Finger, Peter J. Gough, Jae U. Jeong, James Kang, Viera Kasparcova, Lara K. Leister, Mukesh K. Mahajan, George Miller, Rakesh Nagilla, Michael T. Ouellette, Michael A. Reilly, Alan R. Rendina, Elizabeth J. Rivera, Helen H. Sun, James H. Thorpe, Rachel D. Totoritis, Wei Wang, Dongling Wu, Daohua Zhang, John Bertin, and Robert W. Marquis
Publication Date (Web): May 9, 2019 (Featured Letter)
DOI: 10.1021/acsmedchemlett.9b00108
Philip A. Harris, Jill M. Marinis, John D. Lich, Scott B. Berger, Anirudh Chirala, Julie A. Cox, Patrick M. Eidam, Joshua N. Finger, Peter J. Gough, Jae U. Jeong, James Kang, Viera Kasparcova, Lara K. Leister, Mukesh K. Mahajan, George Miller, Rakesh Nagilla, Michael T. Ouellette, Michael A. Reilly, Alan R. Rendina, Elizabeth J. Rivera, Helen H. Sun, James H. Thorpe, Rachel D. Totoritis, Wei Wang, Dongling Wu, Daohua Zhang, John Bertin, and Robert W. Marquis
Publication Date (Web): May 9, 2019 (Featured Letter)
DOI: 10.1021/acsmedchemlett.9b00108